AR and Myocardial fibrosis: From the pathological point of view, supratherapeutic androgen exposure affects the cardiovascular system both directly (via cardiac and vascular androgen receptors) and indirectly (via lipid abnormalities, coagulation changes, and neurohormonal shifts), ultimately promoting atherosclerosis, myocardial fibrosis, and electrical instability.